Clinical Trials Browser

Phase 2 × Hemangiosarcoma × balstilimab × Clear all

NCT04607200 2022-01-11

AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma

Phase 2 Withdrawn

Hemangiosarcoma